TAIMED BIOLOGICS

Building on the success of Trogarzo®, TaiMed is persistently pioneering the evolution and development of a revolutionary long-acting monoclonal antibody (mAb)-based combination therapy using emerging novel technology platforms. Our goal is to establish this therapy as the leading choice for first-line maintenance therapy in HIV. Our vision is to become a globally recognized, highly specialized company in HIV drug development, addressing the critical and unmet medical needs of patients worldwide... Taiwan possesses a highly educated talent pool, a stable business environment, and well-established regulations, making it an ideal choice for global CDMO services.Our qualified cGMP facility and CDMO service team strive to provide comprehensive services, including cGMP manufacturing, process development, analysis & analytical method development, formulation development, regulatory affairs, and more. We are committed to delivering reliable and high-quality services, offering competitive..

Also known as: TaiMed, TaiMed Biologics, Inc.

Primary location: Hsinchu Taiwan (r.o.c.)